Yes, you saw it right. Almost $1B for a preclinica
Post# of 72440
B-UP is a lock to advance to Phase 2b. Cha-ching!
Quote:
J&J will pay Protagonist $125 million if it moves the drug into phase 2b and a further $200 million if it sticks with the asset after getting a look at data from the trial.